Clinuvel Pharmaceuticals Ltd (CUVL) › EPS (Diluted)Clinuvel Pharmaceuticals Ltd (CUVL): EPS (Diluted)Annual figures by period end, from SEC filings.$0.46Year ended 2026-06-302024-06-30: $0.462025-06-30: $0.462026-06-30: $0.46$0.462024-06-30 EPS (Diluted) (USD per share) 2026-06-30Period endedEPS (Diluted)Change YoYSource filing2026-06-30$0.460.0%2026-10-30, From 2025-07-012025-06-30$0.460.0%2026-10-30, From 2024-07-012024-06-30$0.46n/a2026-10-30, From 2023-07-01Other metrics: RevenueCost of RevenueGross ProfitR&D ExpenseOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShare RepurchasesDividends PaidShares OutstandingWeighted Average Diluted SharesEPS (Basic)